Gabapentin (Neurontin) as Add‐on Therapy in Patients with Partial Seizures: A Double‐Blind, Placebo‐Controlled Study

Epilepsia

Volumn 35, Issue 4, 1994, Pages 795-801

  Anhut, H ^a   Ashman, P ^b   Feuerstein, T J ^a   Sauermann, W ^c   Saunders, M ^b   Schmidt, B ^d  

^a Parke Davis Pharmaceutical Research   (Germany)

^b Warner Lambert Company ^*  (United Kingdom)

^c Datamap GmbH   (Germany)

^d NONE   (Germany)

Author keywords

Adverse events; Anticonvulsants; Clinical trials; Drug evaluation; Epilepsy; Gabapentin; Seizures

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; PHENYTOIN; PLACEBO; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANTICONVULSANT THERAPY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DIPLOPIA; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FATIGUE; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETIC ACIDS; ADOLESCENT; ADULT; AGED; AMINES; ANTICONVULSANTS; CHILD; CHRONIC DISEASE; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EPILEPSIES, PARTIAL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0028041242     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1994.tb02513.x     Document Type: Article

References (24)

1. Drug interaction study of the new anticonvulsant gabapentin with phenytoin in epileptic patients [Abstract 507]
2. Double‐blind crossover trial of lamotrigine (Lamictal) as add‐on therapy in intractable epilepsy
3. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
4. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes
5. Gabapentin as an antiepileptic drug in man
6. Potential antiepileptic drugs: lamotrigine
7. Effect of gabapentin on carbamazepine levels
8. 3h]gabapentin to a novel site in rat brain: autoradiographic studies
9. Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin
10. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures
11. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic‐clonic seizures
12. Meta‐analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy
13. General principles: how to use antiepileptic drugs
14. Lack of interaction of gabapentin (Neurontin) with carbamazepine or valproate
15. Monotherapy or polytherapy for epilepsy
16. Potential antiepileptic drugs: vigabatrin
17. Potential antiepileptic drugs. Gabapentin
18. Two antiepileptic drugs for intractable epilepsy with complex partial seizures
19. Double‐blind study of gabapentin in the treatment of partial seizures
20. 3H]‐gabapentin binding to a novel site in rat brain: homogenate binding studies
21. Pharmacology of gabapentin, a novel anticonvulsant, in vitro and in experimental animals
22. UK Gabapentin Study Group. Gabapentin in partial epilepsy
23. US Gabapentin Study Group No. 5. Gabapentin as add‐on therapy in refractory partial epilepsy: a double‐blind, placebo‐controlled, parallel‐group study
24. Pharmacokinetics and metabolism of gabapentin in rat, dog and man